Close Menu
Home » chlamydia

chlamydia

Jul 29, 2014

U of Maryland Wins $10.7M for STI/STD Center, Omics Research Projects

NEW YORK (GenomeWeb) – The University of Maryland's Schools of Dentistry and Medicine said today they have jointly received a $10.7 million grant from the National Institute of Allergy and Infectious Diseases to use omics methods to identify molecular biomarkers related to sexually transmitted in

Jul 28, 2014

FDA Clears BD Chlamydia, Gonorrhea Assays

NEW YORK (GenomeWeb) – BD Diagnostics said today the US Food and Drug Administration has cleared for marketing the BD ProbeTec Chlamydia trachomatis Qx Amplified DNA Assay and the BD ProbeTec Neisseria gonorrhea Qx Amplified DNA Assay on the BD Viper LT system.

Apr 29, 2014

Atlas Genetics Completes Final Tranche of $28.4M Series B Financing

NEW YORK (GenomeWeb) – Atlas Genetics today announced it completed the final tranche of its £16.9 million ($28.4 million) Series B financing to complete the transfer to manufacture of its io molecular diagnostics system and file for regulatory approval of the first test for chlamydia.

Feb 27, 2014

Wave 80 Receives SBIR Grant to Develop No-spin Sample Prep for Chlamydia MDx

Premium

Molecular diagnostic company Wave 80 Biosciences has received Phase I Small Business Innovation Research funding from the National Institutes of Health to develop rapid sample prep to support chlamydia testing in low-resource settings.

Feb 11, 2014

Quidel Q4 Revenues Shrink 7 Percent on Softer Flu Business; MDx Projects Remain on Track

NEW YORK (GenomeWeb News) – Quidel reported after the close of the market on Tuesday that its fourth quarter revenues declined 7 percent year over year on slower influenza and respiratory disease business.

Feb 06, 2014

New Hologic CEO Sees Promise in Former Gen-Probe Unit as Firm Seeks Return to Organic Growth

Premium

Hologic this week reported a 3 percent year-over-year decline in fiscal first-quarter revenues, including a 7 percent drop in revenues in its Diagnostics division.

Dec 12, 2013

Estonian Group Validates Point-of-Care Chlamydia Assay Featuring Isothermal RPA Technology

Premium

A team from Estonia's University of Tartu and molecular diagnostics startup Selfdiagnostics has published a peer-reviewed study describing and clinically validating a recently developed point-of-care molecular assay to diagnose chlamydia infections.

Dec 05, 2013

Simultaneous RNA-seq of Host and Bacterial Invader Offer Glimpse into Disease Processes

NEW YORK (GenomeWeb News) – By turning to a simultaneous RNA-seq strategy, researchers at the University of Maryland School of Medicine profiled the transcriptomes of Chlamydia trachomatis and the host cells the bacteria infected, gaining a glimpse into how disease is established and cau

Jun 06, 2013

Quest, Hologic Enter Deal to Improve Women's Health

NEW YORK (GenomeWeb News) – Quest Diagnostics and Hologic today announced an alliance aimed at improving women's health.

Apr 25, 2013

Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent

Premium

Cepheid's Xpert CT/NG assay for the detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae, launched in the US at the start of the year, has seen the greatest uptake of any new Xpert test since Xpert MRSA, President and CEO John Bishop

Pages

The Scan

After Your Number

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Not Quite How It Works

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Research, But Not in Name

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

Science Finds Support for Gene Drives Depends on Species Targeted, Ability to Control Drive; More

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.